Leveraging mRNA technology to accelerate HIV vaccine development

Charlotte Barker, Editor, BioInsights, speaks to (pictured) Mark Feinberg, President & CEO, IAVI (formerly known as the International AIDS Vaccine Initiative) to explore how the nonprofit is bringing the latest advances in vaccine science to the fight against HIV and other diseases disproportionately affecting people living in low-income countries.

Please enter your email to access content Read now